B.M.K. Donato

1.0k total citations · 1 hit paper
47 papers, 660 citations indexed

About

B.M.K. Donato is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B.M.K. Donato has authored 47 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Economics and Econometrics and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B.M.K. Donato's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Diabetes Treatment and Management (8 papers) and Chronic Disease Management Strategies (4 papers). B.M.K. Donato is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Diabetes Treatment and Management (8 papers) and Chronic Disease Management Strategies (4 papers). B.M.K. Donato collaborates with scholars based in United States, Canada and Germany. B.M.K. Donato's co-authors include Scott D. Ramsey, Nadia Howlader, Ruth Etzioni, Shelagh M. Szabo, Michael P. Porter, Karissa Johnston, Marcelo Eidi Nita, Javed Butler, Thomas M. O’Connell and Mikhail Kosiborod and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

B.M.K. Donato

38 papers receiving 648 citations

Hit Papers

Prevalence and Overlap of Cardiac, Renal, and Metabolic C... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
    2023 107 citations John W. Ostrominski, Jamie S. Hirsch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.M.K. Donato United States 12 147 147 145 108 99 47 660
Ingela Björholt Sweden 14 253 1.7× 167 1.1× 227 1.6× 57 0.5× 52 0.5× 32 656
Bingcao Wu United States 15 70 0.5× 161 1.1× 45 0.3× 148 1.4× 117 1.2× 63 690
I‐Chun Thomas United States 15 107 0.7× 356 2.4× 94 0.6× 33 0.3× 70 0.7× 39 644
Teresa Zyczynski United States 15 115 0.8× 118 0.8× 115 0.8× 48 0.4× 302 3.1× 44 1.0k
Carlos Crespo Spain 13 75 0.5× 145 1.0× 27 0.2× 95 0.9× 89 0.9× 65 583
Eugene B. Cone United States 13 112 0.8× 253 1.7× 173 1.2× 37 0.3× 31 0.3× 49 652
Parth K. Modi United States 17 218 1.5× 506 3.4× 138 1.0× 21 0.2× 56 0.6× 82 839
Trevor Thompson United States 18 245 1.7× 446 3.0× 492 3.4× 125 1.2× 125 1.3× 32 1.2k
David Williams Canada 16 283 1.9× 200 1.4× 114 0.8× 82 0.8× 34 0.3× 32 868

Countries citing papers authored by B.M.K. Donato

Since Specialization
Citations

This map shows the geographic impact of B.M.K. Donato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.M.K. Donato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.M.K. Donato more than expected).

Fields of papers citing papers by B.M.K. Donato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.M.K. Donato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.M.K. Donato. The network helps show where B.M.K. Donato may publish in the future.

Co-authorship network of co-authors of B.M.K. Donato

This figure shows the co-authorship network connecting the top 25 collaborators of B.M.K. Donato. A scholar is included among the top collaborators of B.M.K. Donato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.M.K. Donato. B.M.K. Donato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabo, Shelagh M., et al.. (2025). Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review. Journal of Managed Care & Specialty Pharmacy. 31(9). 851–861.
2.
Ostrominski, John W., Anindit Chhibber, Effie Kuti, Brendan Clark, & B.M.K. Donato. (2025). Obesity Medication Treatment Perspectives Among People with Overweight or Obesity. Patient Preference and Adherence. Volume 19. 2887–2899.
3.
4.
Briggs, Andrew, Ciaran Kohli‐Lynch, Satabdi Chatterjee, et al.. (2024). A Contemporary Economic Model of CKD in the United States. Journal of the American Society of Nephrology. 35(10S).
5.
Anzueto, Antonio, et al.. (2024). Treatment patterns in patients with newly diagnosed COPD in the USA. BMC Pulmonary Medicine. 24(1). 395–395. 2 indexed citations
6.
Peasah, Samuel K., Yan Huang, Swetha Palli, et al.. (2023). Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement. Journal of Managed Care & Specialty Pharmacy. 29(2). 152–160. 1 indexed citations
7.
Crowe, Christopher L., Effie Kuti, B.M.K. Donato, et al.. (2023). Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID ‐19. Diabetes Obesity and Metabolism. 25(9). 2464–2472.
8.
Myers, Laura C., et al.. (2022). Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease. Respiratory Medicine. 206. 107064–107064. 2 indexed citations
9.
Cheung, Antoinette, et al.. (2022). IMPACT OF CARING FOR INDIVIDUALS WITH HEART FAILURE IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW. Journal of the American College of Cardiology. 79(9). 439–439. 2 indexed citations
10.
Kaiser, Karen, Susan Yount, Kimberly Webster, et al.. (2020). <p>Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)</p>. Patient Preference and Adherence. Volume 14. 705–715. 8 indexed citations
11.
12.
Szabo, Shelagh M., Ioannis Tomazos, Anna Petryk, et al.. (2019). Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review. Orphanet Journal of Rare Diseases. 14(1). 85–85. 29 indexed citations
13.
Donato, B.M.K., et al.. (2016). Methods Of Sample Size Calculation In Retrospective Burden Of Illness Studies. Value in Health. 19(3). A101–A101. 3 indexed citations
14.
Johnston, Karissa, et al.. (2015). Health Care Resource Utilization and Costs in Individuals with Atrial Fibrillation in United Arab Emirates and Kingdom of Saudi Arabia: A Retrospective Cohort Study. 4(2). 17–25. 7 indexed citations
15.
Caporale, Joaquín, et al.. (2012). PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care System. Value in Health. 15(4). A119–A120. 1 indexed citations
16.
Stefani, Stephen, et al.. (2012). PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System. Value in Health. 15(7). A419–A420. 1 indexed citations
17.
Nita, Marcelo Eidi, et al.. (2012). PCV123 VIP Study: Venous Thromboembolism Prophylaxis Patterns and Drug Use in Patients Undergoing Total Knee and Hip Arthroplasty in Brazil. Value in Health. 15(7). A384–A384. 1 indexed citations
18.
Augustovski, Federico, Jorge Díaz, Marcos Bosi Ferraz, et al.. (2012). Status Update of the Reimbursement Review Environment in the Public Sector across Four Latin American Countries. Value in Health Regional Issues. 1(2). 223–227. 3 indexed citations
19.
Juarez-Garcia, A., et al.. (2012). PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa. Value in Health. 15(4). A180–A180. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingela Björholt Breakdown of academic impact, for papers by Bingcao Wu Breakdown of academic impact, for papers by I‐Chun Thomas Breakdown of academic impact, for papers by Teresa Zyczynski Breakdown of academic impact, for papers by Carlos Crespo Breakdown of academic impact, for papers by Eugene B. Cone Breakdown of academic impact, for papers by Parth K. Modi Breakdown of academic impact, for papers by Trevor Thompson Breakdown of academic impact, for papers by David Williams
Rankless by CCL
2026